Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




AI Accurately Predicts Prematurity Complications in Newborns from Blood Samples

By LabMedica International staff writers
Posted on 27 Jan 2026

Premature birth is a leading cause of infant illness and long-term disability. More...

However, doctors still struggle to predict which newborns will develop serious complications affecting the brain, lungs, eyes, or digestive system. Babies born at the same gestational age and weight can follow very different medical paths, making early clinical decision-making difficult. Researchers have now shown that patterns hidden in routine blood samples collected shortly after birth can be used to forecast these medical trajectories, offering a way to anticipate and potentially prevent complications of prematurity.

Researchers from Stanford Medicine (Stanford, CA, USA) applied artificial intelligence (AI) to analyze biochemical data already collected through routine newborn screening programs. Using small blood spots obtained at birth, the AI model examined metabolic markers such as amino acids and fat breakdown products. These measurements were combined with basic clinical information to create a metabolic health index capable of distinguishing different biological forms of prematurity rather than treating all early births as a single condition.

The researchers analyzed data from 13,536 premature infants born in California and validated the results using an independent cohort of 3,299 preterm infants from Ontario, Canada. The AI system identified molecular patterns linked to four major prematurity complications, including lung, intestinal, eye, and brain disorders. The findings, published in Science Translational Medicine, showed that a set of six blood-based measurements, combined with clinical factors, predicted individual complications with more than 85 percent accuracy.

The findings suggest that prematurity is not a single condition but a collection of distinct biological pathways that lead to different outcomes. Early risk prediction could help determine which infants need specialized neonatal intensive care and allow physicians to tailor monitoring and treatment strategies from birth. Researchers plan to expand the model by integrating maternal health data, electronic medical records, and additional biological measurements, with the long-term goal of preventing complications before they fully develop.

“The goal is to have a whole new taxonomy of prematurity, so you can see where a child is headed and understand what is causing differences in their health trajectories,” said study co-author David Stevenson, MD, “That will allow us to intervene, prevent, and treat complications.”

Related Links:
Stanford Medicine


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Pathology

view channel
AI: Artificial intelligence; CNN: Convolutional neural networks; ResNet: Residual neural network. (Xing-hua Gao from The First Hospital of China Medical University, China Image Source Link: https://www.ovid.com/jnls/cmj/fulltext/10.1097/cm9.0000000000004154~deep-learning-based-computational-pathology-technologies)

Review Highlights Progress and Validation Needs for AI in Digital Pathology

Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.